Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06361589
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2024-03-26
Brief Title:
Real World Study of Lolatinib for Advanced ALK NSCLC Patients
Sponsor:
Organization:
Sichuan Cancer Hospital and Research Institute